OrthoPediatrics Corp. has announced an agreement to acquire Pega Medical in a transaction valued up to $33 million, according to a press release.
OrthoPediatrics will add to its trauma and deformity portfolio with the acquisition of Pega Medical’s products, which include the Fassier-Duval Telescopic Intramedullary System, an implant designed to treat bony deformities in pediatric patients with osteogenesis imperfecta.
“We are excited to announce the agreement to acquire Pega Medical. Similar to OrthoPediatrics, the Pega organization has been focused exclusively on addressing unmet needs for children whose lives have been impacted by musculoskeletal disorders and diseases,” David Bailey, CEO of OrthoPediatrics, said in the release. “Their product offerings include novel technologies to treat some of the most unique conditions in pediatric orthopedics.”